Drugmaker Ipsen posts jump in profit, eyes stable margin in 2014
February 28, 2014 at 02:56 AM EST
PARIS, Feb 28 (Reuters) - French drugmaker Ipsen returned to net profit in 2013, lifted by sales of specialty care drugs, and aims to preserve its margin as it prepares a U.S. launch of its Somatuline treatment against neuroendocrine tumors.
